Isogenica

Isogenica operates a range of discovery platforms supported by state-of-the-art methodologies for identifying antibody and peptide ligands.

Isogenica is a company in biopharma, biotechnology, health care, life science based in Europe, Middle East, and Africa (EMEA), founded in 2000.

The company sits in the biopharma, biotechnology, health care, life science segment, where it competes on its core product or service.

Europe, Middle East, and Africa (EMEA) is where the company is located.

The company is listed at the Grant stage of development.

The company reports a headcount in the c_00011_00050 range.

Public records show total funding of about $9M.

Website: www.isogenica.com